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Editorial 519 Acute hepatitis C virus and cardiac surgeons
R. Scott Thurston, MD, FACS, Baton Rouge, LA
Point/Counterpoint 521 Point: Minimally invasive bipolar radiofrequency ablation of lone atrial
fibrillation: Early multicenter results
Erik Beyer, MD, Richard Lee, MD, and Buu-Khanh Lam, MD, Temple, Texas, Chicago, Illinois,
Ottawa, Canada
Lone AF can be treated safely and efficaciously by minimally invasive epicardial bipolar
radiofrequency ablation. The results are most encouraging for patients with paroxysmal or persistent
AF. Long-term prospective results are required to further validate this modality as a therapeutic
option to treat lone AF.
527 Counterpoint:Minimally invasive bipolar radiofrequency ablation of lone atrial
fibrillation: Early multicenter results
Richard J. Shemin, MD, Los Angeles, Calif
Congenital Heart
Disease (CHD)
529 Brain maturation is delayed in infants with complex congenital heart defects
Daniel J. Licht, MD, David M. Shera, ScD, Robert R. Clancy, MD, Gil Wernovsky, MD,
Lisa M. Montenegro, MD, Susan C. Nicolson, MD, Robert A. Zimmerman, MD,
Thomas L. Spray, MD, J. William Gaynor, MD, and Arastoo Vossough, MD,
Philadelphia, Pennsylvania
Structural brain maturation in infants with HLHS and TGA was assessed by total maturation scores,
a validated MRI measure of development. Significant maturational delays were found, consistent
with the findings of smaller head circumferences and immature cortical folding patterns seen in this
population.
538 Congenital supravalvar mitral ring: An underestimated anomaly
Alessandra Toscano, MD, PhD, Luciano Pasquini, MD, FESC, Roberta Iacobelli, MD,
Roberto M. Di Donato, MD, Francesca Raimondi, MD, Adriano Carotti, MD,
Vincenzo Di Ciommo, MD, and Stephen P. Sanders, MD, FACC, Rome, Italy
Congenital mitral ring can be supramitral or intramitral, and mitral stenosis can develop rapidly
during infancy. Surgical prognosis depends on the underlying valve anatomy. Recognition of mitral
ring is important because surgical results are better than for other forms of congenital mitral stenosis.
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543 Factors predicting the progress of mitral valve disease in surgically treated
adults with ostium primum atrial septal defects
Vijay Agarwal, MCh, FRCS, Suneil Kumar Aggarwal, MRCP, and Choudary D. Voleti, MD, FACS,
Prashantigram, India
Fifty-one adult patients operated on for ostium primum atrial septal defects were studied
retrospectively to identify factors influencing progression of mitral valve disease. Most had good
outcomes, although female sex and preoperative pulmonary arterial hypertension had adverse effects.
We recommend regular echocardiographic follow-up to assess mitral regurgitation.
548 Specific issues after surgical repair of partial atrioventricular septal defect:
Actuarial survival, freedom from reoperation, fate of the left atrioventricular
valve, prevalence of left ventricular outflow tract obstruction, and other
events
Ujjwal K. Chowdhury, MCh, Diplomate NB, Balram Airan, MCh, Amber Malhotra, MCh,
Akshay K. Bisoi, MCh, Mani Kalaivani, MSc (Biostatistics), Raghu M. Govindappa, MS, and
Panangipalli Venugopal, MCh, New Delhi, India
A total of 132 consecutive patients with partial AVSD undergoing surgical repair were studied to
identify the morphologic characteristics and other risk factors for continuing mortality and morbidity
after surgery. The risk of death was 38 times higher in patients with grossly malformed left
atrioventricular valve.
556 Minimally invasive perventricular device closure of an isolated
perimembranous ventricular septal defect with a newly designed delivery
system: Preliminary experience
Xing Quansheng, MD, Pan Silin, MS, Zhuang Zhongyun, BS, Rong Youbao, BS, Li Shengde, MS,
Cao Qian, MS, Duan Shuhua, BS, Hou Kefeng, BS, Ji Zhixian, MS, and Wu Qin, MS, Qingdao and
Shanghai, China
We describe the preliminary experience of minimally invasive transthoracic device closure of
a perimembranous ventricular septal defect under transesophageal echocardiographic guidance
without cardiopulmonary bypass. During the clinical interventions, no complications were noticed.
560 Fontan hemodynamics: Importance of pulmonary artery diameter
Lakshmi P. Dasi, PhD, Resmi KrishnankuttyRema, MS, Hiroumi D. Kitajima, PhD,
Kerem Pekkan, PhD, Kartik S. Sundareswaran, MS, Mark Fogel, MD, Shiva Sharma, MD,
Kevin Whitehead, MD, PhD, Kirk Kanter, MD, and Ajit P. Yoganathan, PhD, Atlanta and
Lawrenceville, Ga, Philadelphia, Pa
We studied 11 extracardiac and 11 lateral tunnel Fontan procedures to correlate anatomic
characteristics with energy loss and resting cardiac output. Energy loss and cardiac output strongly
correlated with minimum cross section of the pulmonary arteries near the Fontan connection, with no
appreciable difference between extracardiac and lateral tunnel procedures.
General Thoracic
Surgery (GTS)
565 Is botulinum toxin injection of the pylorus during Ivor–Lewis
esophagogastrectomy the optimal drainage strategy?
Robert James Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD,
Cheri L. Canon, MD, Roopa Dhawan, BS, and Mohamad A. Eloubeidi, MD, Birmingham, Ala
A retrospective study of 221 patients who underwent Ivor–Lewis esophagogastrectomy suggests that
the injection of botulinum toxin into the pylorus during surgical intervention might reduce operative
time, improve early gastric emptying, reduce respiratory complications, and decrease late bile reflux.
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573 Tailored cricoplasty: An improved modification for reconstruction in subglottic
tracheal stenosis
Moishe Liberman, MD, and Douglas J. Mathisen, MD, Boston, Mass
Tailored cricoplasty, a modification of the technique of laryngotracheal resection and reconstruction
for the surgical treatment of subglottic stenosis, results in additional horizontal enlargement of the
luminal diameter of the airway of 3 to 5 mm in most patients and is associated with high levels of
patient satisfaction.
580 Expression of LKB1 tumor suppressor in non–small cell lung cancer determines
sensitivity to 2-deoxyglucose
Landon J. Inge, PhD, Keith D. Coon, PhD, Michael A. Smith, MD, and Ross M. Bremner, MD, PhD,
Phoenix, Ariz
Treatment of NSCLC is primarily limited to surgery, radiation, and chemotherapy. We have targeted
NSCLC cells lacking the tumor suppressor LKB1 with the glycolytic inhibitor 2-deoxyglucose. The
inability of LKB1-null NSCLC cells to adapt to glycolytic inhibition results in increased cell death,
representing a possible treatment option for NSCLC.
587 Predictors of major morbidity and mortality after esophagectomy for
esophageal cancer: A Society of Thoracic Surgeons General Thoracic Surgery
Database risk adjustment model
Cameron D. Wright, MD, John C. Kucharczuk, MD, Sean M. O’Brien, PhD, Joshua D. Grab, MS,
and Mark S. Allen, MD, Boston, Mass, Philadelphia, Pa, Durham, NC, Rochester, Minn
We identified important predictors of major morbidity and mortality after esophagectomy using the
Society of Thoracic Surgeons prospective database of 2315 esophagectomies. A strong volume
performance relationship for a composite measure of morbidity and mortality was not observed
among participants in this database.
597 Stereotactic radiosurgery for the treatment of stage I non–small cell lung cancer
in high-risk patients
Arjun Pennathur, MD, James D. Luketich, MD, Dwight E. Heron, MD, Ghulam Abbas, MD,
Steven Burton, MD, Mang Chen, MD, William E. Gooding, MS, Cihat Ozhasoglu, PhD,
Rodney J. Landreneau, MD, and Neil A. Christie, MD, Pittsburgh, Pa
Stereotactic radiosurgery (median dose 20 Gy) was used to treat high-risk patients with stage
I non–small cell lung cancer. Estimated overall 1-year survival was 81%; local progression at
median 21-month follow-up was 42%. Stereotactic radiosurgery is safe; however, further
studies with multiple fractions are required to evaluate its efficacy.
605 Change in maximum standardized uptake value on repeat positron emission
tomography after chemoradiotherapy in patients with esophageal cancer
identifies complete responders
Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD, Amar A. Talati, BS,
Robert M. Cerfolio, and Thomas S. Winokur, MD, Birmingham, Alabama
The percent change in the maximum standardized uptake value on a repeat PET scan performed on
patients with esophageal cancer (at the same center$ 30 days after neoadjuvant chemoradiotherapy
finishes) is a predictor of a patient’s response. When it decreases by 64% or more, the patient is
probably a pathologic complete responder.
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610 Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall:
A population-based Scandinavian Sarcoma Group study of 106 patients
Bjo¨rn Widhe, MD, and Prof. Henrik C. F. Bauer, MD, PhD, Stockholm, Sweden
Surgical treatment is decisive in outcome for chondrosarcoma of the chest wall. Patients operated
with wide surgical margins had fewer local recurrence and better overall survival. Sarcoma centers
with high volume of patients achieved better outcome than those treated at nonspecialty centers.
615 CXCL12 and CXCR4 in adenocarcinoma of the lung: Association with
metastasis and survival
Patrick L. Wagner, MD, Elizabeth Hyjek, MD, Madeline F. Vazquez, MD, Danish Meherally, MPH,
Yi Fang Liu, MD, Paul A. Chadwick, BS, Tatiana Rengifo, BS, Gabriel L. Sica, MD,
Jeffrey L. Port, MD, Paul C. Lee, MD, Subroto Paul, MD, Nasser K. Altorki, MD, and
Anjali Saqi, MD, New York, NY, Chicago, Ill
The chemokine CXCL12 and its receptor CXCR4 are implicated in metastasis of non–small cell lung
carcinoma (NSCLC). Using immunohistochemical staining to quantitate expression in 154 NSCLCs,
we determined that cytomembranous CXCR4 expression is an independent indicator of poor
prognosis in adenocarcinoma, whereas nuclear expression of this molecule is associated with
a survival benefit.
622 Survival according to the site of bronchial microscopic residual disease after
lung resection for non–small cell lung cancer
Ste´phane Collaud, MD, Massimo Bongiovanni, MD, Jean–Claude Pache, MD, Ge´rald Fioretta, MS,
and John H. Robert, MD, Geneva, Switzerland
Non–small cell lung cancer (NSCLC) bronchial R1 resections that demonstrate submucosal or
lymphatic involvement have a poor prognosis. In contrast, R1 resections with disease limited to the
epithelium do not seem to affect survival in patients with stage I and II NSCLC.
Acquired Cardiovascular
Disease (ACD)
627 Evolution in the management of the total thoracic aorta
Tad Kim, MD, Tomas D. Martin, MD, W. Anthony Lee, MD, Philip J. Hess, Jr, MD,
Charles T. Klodell, MD, Curtis G. Tribble, MD, Robert J. Feezor, MD, and
Thomas M. Beaver, MD, MPH, Gainesville, Fla
Extensive thoracic aortic aneurysms are technically challenging and traditionally repaired with
a 2-stage elephant trunk technique. With the advent of endovascular stent grafts, alternatives became
available for repairing the total thoracic aorta in 1 or 2 stages. We compare outcomes of 2-stage
elephant trunk, single-stage, and hybrid endovascular repairs.
635 Management of moderate functional mitral regurgitation at the time of aortic
valve replacement: Is concomitant mitral valve repair necessary?
Calvin K. N. Wan, MD, Rakesh M. Suri, MD, Zhuo Li, MS, Thomas A. Orszulak, MD,
Richard C. Daly, MD, Hartzell V. Schaff, MD, and Thoralf M. Sundt, III, MD, Rochester,
Minnesota
Among 190 patients with moderate functional MR undergoing AVR without mitral intervention,
MR improved in the majority. Survival was similar to patients case matched for LVEF without
MR undergoing AVR.
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641 Valve-sparing and valve-replacing techniques for aortic root replacement in
patients with Marfan syndrome: Analysis of early outcome
Irina V. Volguina, PhD, D. Craig Miller, MD, Scott A. LeMaire, MD, Laura C. Palmero, MPH,
Xing Li Wang, MD, PhD, Heidi M. Connolly, MD, Thoralf M. Sundt, III, MD, Joseph E. Bavaria,
MD, Harry C. Dietz, MD, Dianna M. Milewicz, MD, PhD, and Joseph S. Coselli, MD, on behalf of the
Aortic Valve Operative Outcomes in Marfan Patients study group, Houston, Tex, Stanford, Calif,
Rochester, Minn, Philadelphia, PA, Baltimore, MD
Analysis of 46 valve-replacing and 105 valve-sparing aortic root replacements in patients with
Marfan syndrome was performed within a prospective, international registry study involving 18
institutions. There were no early deaths. Despite the added complexity of valve-sparing procedures,
there were no significant differences in the incidence of 30-day adverse events or valve-related
complications.
650 Off-pump versus on-pump myocardial revascularization in patients with
ST-segment elevation myocardial infarction: A randomized trial
Khalil Fattouch, MD, PhD, Francesco Guccione, MD, Pietro Dioguardi, MD, Roberta Sampognaro,
MD, Egle Corrado, MD, Marco Caruso, MD, and Giovanni Ruvolo, MD, Palermo, Italy
Conventional cardioplegic arrest coronary artery bypass grafting after ST-segment elevating
myocardial infarction is associated with high mortality and morbidity. The benefits of off-pump
surgery have been suggested. This study randomly evaluated the impact of the off-pump technique on
clinical results.
658 Metabolic syndrome is an independent risk factor for stroke and acute renal
failure after coronary artery bypass grafting
Kan Kajimoto, MD, PhD, Katsumi Miyauchi, MD, Takatoshi Kasai, MD, PhD,
Naotake Yanagisawa, MB, Taira Yamamoto, MD, Keita Kikuchi, MD, PhD, Takeshi Nakatomi, MD,
Hiroshi Iwamura, MD, Hiroyuki Daida, MD, and Atsushi Amano, MD, Tokyo, Japan
Patients with metabolic syndrome had increased risk of postoperative stroke and acute renal failure
after coronary artery bypass surgery. We should recognize metabolic syndrome as a novel risk factor
for adverse events after coronary artery bypass surgery.
664 Effects of endoscopic thoracic sympathectomy for primary hyperhidrosis on
cardiac autonomic nervous activity
Jorge Cruz, MD, PhD, Joa˜o Sousa, MD, Antonio G. Oliveira, MD, PhD, and
Luis Silva-Carvalho, MD, PhD, Lisbon, Portugal
Cardiac autonomic effects of endoscopic thoracic sympathectomy were evaluated in a prospective
study of 38 patients with primary hyperhidrosis through 24-hour Holter recordings before and 6
months after sympathectomy. Postsympathectomy changes in both time and frequency domains
reflect increased vagal and global cardiac autonomic activity and decreased sympathetic activity after
sympathectomy.
670 Ministernotomy versus conventional sternotomy for aortic valve replacement:
A systematic review and meta-analysis
Morgan L. Brown, MD, Stephen H. McKellar, MD, Thoralf M. Sundt, MD, and
Hartzell V. Schaff, MD, Rochester, Minn
Approaches have been developed to make aortic valve replacement operations less invasive through
a partial upper sternotomy rather than a conventional full sternotomy. This review and meta-analysis
analyzed comparative series and concluded that partial upper sternotomy can be performed safely but
has few advantages.
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680 Treatment of aortic stenosis with aortic valve bypass (apicoaortic conduit)
surgery: An assessment using computational modeling
Elias Balaras, PhD, K. S. Cha, PhD, Bartley P. Griffith, MD, and James S. Gammie, MD,
Baltimore, Md
Computational fluid dynamic modeling demonstrated that aortic valve bypass (AVB) surgery
effectively relieves valvular aortic stenosis. Conduit flow varied between 40% and 55% of total
cardiac output depending on the diameter of the conduit. Post-AVB cerebral blood flow was
unchanged and was constant across all conduit sizes modeled.
Cardiothoracic
Transplantation (TX)
688 Does reperfusion injury still cause significant mortality after lung
transplantation?
Gorav Ailawadi, MD, Christine L. Lau, MD, Philip W. Smith, MD, Brian R. Swenson, MD, MS,
Sara A. Hennessy, MD, Courtney J. Kuhn, Lynn M. Fedoruk, MD, Benjamin D. Kozower, MD,
Irving L. Kron, MD, and David R. Jones, MD, Charlottesville, Va
The mortality from reperfusion injury (RI) after lung transplantation has improved over time. RI is as
frequent but less severe in the current era than previously. Furthermore, survival with extracorporeal
membrane oxygenation has improved. These findings account for our improved early mortality after
lung transplantation in recent years.
695 CD41 T lymphocytes mediate acute pulmonary ischemia–reperfusion injury
Zequan Yang, MD, PhD, Ashish K. Sharma, MBBS, Joel Linden, PhD, Irving L. Kron, MD, and
Victor E. Laubach, PhD, Charlottesville, Va
Using an in vivo mouse model, we found that sequential recruitment of CD41 T cells and neutrophils
mediates lung ischemia–reperfusion injury. Injury is reduced by neutrophil depletion or depletion of
CD41, but not CD81, T cells. CD41 T cell depletion results in reduced cytokine/chemokine
production and reduced neutrophil chemotaxis into the lung.
Evolving Technology (ET) 703 A new strategy for prevention of anastomotic stricture using tacrolimus-eluting
biodegradable nanofiber
Masato Mutsuga, MD, Yuji Narita, MD, PhD, Aika Yamawaki, BMedEng, Makoto Satake, PhD,
Hiroaki Kaneko, PhD, Yoshihiro Suematsu, MD, PhD, Akihiko Usui, MD, PhD, and
Yuichi Ueda, MD, PhD, Nagoya, Aichi, Hino, and Tokyo, Japan
We developed a novel sustained drug-releasing device to prevent anastomotic stricture using a nano-
scale ‘‘cotton-wool’’ configuration fiber, an immunosuppressive agent called ‘‘tacrolimus-eluting
biodegradable nanofiber.’’ This new material reduced neointimal hyperplasia and preserved
endothelialization in a rat model.
710 Effect of work-hour restriction on operative experience in cardiothoracic
surgical residency training
Rafe C. Connors, MD, John R. Doty, MD, David A. Bull, MD, Heidi T. May, David A. Fullerton, MD,
and Robert C. Robbins, MD, Salt Lake City and Murray, UT, Aurora, Co, Stanford, Calif
Resident work-hour reform has affected the number of cases residents complete as the primary
surgeon during fellowship training. In a time of increasingly complex cases, reduction in resident case
volumes because of work-hour restrictions and decreasing cardiac cases might lead to inadequate
operative experience.
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Cardiopulmonary
Support (CSP)
714 Dynamic fluid shifts induced by fetal bypass
R. Scott Baker, BS, Christopher T. Lam, BS, Emily A. Heeb, and Pirooz Eghtesady, MD, PhD,
Cincinnati, OH
In a midgestation ovine model, fetal bypass leads to significant fluid shifts during bypass
(approximately 100 mL/kg) and decreasing fetal plasma volume after bypass, correlating with
increasing vasopressin levels but not changing osmolarity. Overall losses averaged
0.8 mL $ kg21 $ min21 but were not accounted for by placental or organ edema.
Fetal rehydration is necessary after bypass.
723 Acute hyperglycemia enhances oxidative stress and exacerbates myocardial
infarction by activating nicotinamide adenine dinucleotide phosphate oxidase
during reperfusion
Zequan Yang, MD, Victor E. Laubach, PhD, Brent A. French, PhD, and Irving L. Kron, MD,
Charlottesville, Va
Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury in mice via oxidative
stress. Potent antioxidant (MPG) reduced infarct size when applied at the onset of reperfusion.
NADPH oxidase inhibitor (apocynin) reduced infarct size only when applied before the onset of
hyperglycemia.
730 Removal of prostaglandin E2 and increased intraoperative blood pressure
during modified ultrafiltration in pediatric cardiac surgery
Kazuto Yokoyama, MD, Shin Takabayashi, MD, PhD, Takuya Komada, MD, PhD, Koji Onoda, MD,
PhD, Yoshihide Mitani, MD, PhD, Hideki Iwata, ME, and Hideto Shimpo, MD, PhD, Tsu, Japan
We investigated the effects of modified ultrafiltration on the relationship between serum
prostaglandin E2 level and intraoperative blood pressure in pediatric cardiac surgery. Removal of
prostaglandin E2 appears to be one of the reasons for increased blood pressure during modified
ultrafiltration.
736 Evaluation of platelet activation in patients supported by the
Jarvik 2000* high–rotational speed impeller ventricular assist device
Christoph Lo¨ffler, MD, Andreas Straub, MD, Nicole Bassler, BA, Katharina Pernice, MD,
Friedhelm Beyersdorf, MD, Christoph Bode, MD, Michael P. Siegenthaler, MD, and
Karlheinz Peter, MD, Freiburg, Germany, and Melbourne, Australia
This study investigated in 8 patients with heart failure the potential association of the high–rotational
speed impeller pump of the Jarvik 2000 ventricular assist device with platelet activation. Flow
cytometry and plasma markers showed no evidence of platelet activation. Considering its clinical
benefits, the Jarvik 2000 represents promising technology.
742 Contractile function is preserved in unloaded hearts despite atrophic
remodeling
Henriette Brinks, MD, Hendrik Tevaearai, MD, MBA, Christian Mu¨hlfeld, MD, Daniela Bertschi,
MD, Brigitta Gahl, MSc, Thierry Carrel, MD, and Marie-Noelle Giraud, PhD, Berne, Switzerland
To investigate atrophic remodeling, we characterize morphologic, cellular, and functional changes
that occur in chronically unloaded normal hearts. We report macroscopic atrophy associated with
maintenance of volume per nucleus of the cardiomyocyte. Contractile function remained intact
despite increased myocardial stiffness.
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Brief Communications:
Clinical
747 Malignant transformation of tracheal inflammatory pseudotumor:A case report
Sayyed Abbas Tabatabaee, MD, Sayyed Mozafar Hashemi, MD, Mojtaba Ahmadi Nejad, MD,
Amir Hosein Davarpanah Jazi, Mohammad Eidy, MD, Parvin Mahzouni, MD, and
Ali Hekmatnia, MD, Isfahan and Khorram Abad, Iran
749 Infective mitral valve myxoma with coronary artery embolization: Surgical
intervention followed by prolonged survival
Feng Yao, MD, Zhi-yun Xu, MD, Yan-lin Liu, MS, and Lin Han, MD, Shanghai,
People’s Republic of China
751 Familial fetal-type rhabdomyoma of the tricuspid valve in the neonate:
Malignant course for a benign disease
Francesca Viscardi, MD, Gabriella Errico, MD, Nicola Schiavo, MD, Paolo Biban, MD,
Alessandro Mazzucco, MD, and Giovanni Battista Luciani, MD, Verona, Italy
753 Diagnosis and management of tritruncal heart in an infant
Glenn J. Pelletier, MD, Mary Sokoloski, MD, and Richard Kardon, DO, Philadelphia, Pa, and
Miami, Fla
756 Left atrial ball thrombus associated with severe left ventricular dysfunction due
to aortic valve stenosis in a patient on dialysis
Masato Nakajima, MD, Koji Tsuchiya, MD, Yuki Okamoto, MD, Kiyotaka Yano, MD, and
Tatsuho Kobayashi, MD, Kofu City, Japan
757 Long-term cardiac remodeling after salvage partial left ventriculectomy in an
infant with anomalous left coronary artery from the pulmonary artery
Stephen Westaby, PhD, MS, FETCS, FECS, FACC, Nick Archer, MD, and
Saul G. Myerson, MD, MRCP, FESC, Oxford, United Kingdom
Brief Communications:
Technical
760 Atrial septal defect repair after a 10-month treatment with bosentan in a patient
with severe pulmonary arterial hypertension: A case report
Konrad Hoetzenecker, MD, Hendrik J. Ankersmit, MD, Diana Bonderman, MD,
Wolfram Hoetzenecker, MD, PhD, Reinald Seitelberger, MD, Walter Klepetko, MD, and
Irene M. Lang, MD, Vienna, Austria, and Tu¨bingen, Germany
762 Use of mitral homograft to support a mechanical valve prosthesis: A feasible
solution for recurrent mitral valve dysfunction
Jose´ M. Bernal, MD, Francisco Gutie´rrez, MD, M. Carmen Farin˜as, MD, Elena Arnaiz, MD,
Carmen Diago, MD, Alejandro Ponto´n, MD, Blanca Ruiz, MD, J. Fernando Val-Bernal, MD, and
Jose´ M. Revuelta, MD, Santander, Spain
763 Concomitant giant coronary artery and coronary sinus aneurysms
Basar Sareyyupoglu, MD, James E. Davies, MD, Grace Lin, MD, and Thoralf M. Sundt, MD,
Rochester, Minn
765 Rapid extracorporeal life support rescue in patients undergoing the Norwood
procedure
Nathalie Roy, MD, Ivan M. Rebeyka, MD, Joseph Atallah, MD, and David B. Ross, MD, Alberta,
Edmonton, Canada
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766 Treatment of anastomotic leaks after esophagectomy with endoscopic hemoclips
Celal Tekinbas, MD, M. Muharrem Erol, MD, Remzi Akdogan, MD, Serdar Turkyilmaz, MD, and
Mehmet Aslan, MD, Trabzon, Turkey
768 Sleeve resection of the left main bronchus for delayed extraction of
a chicken bone
Alper Toker, MD, Serhan Tanju, MD, and Berker Ozkan, MD, Istanbul, Turkey
769 A successful neonatal repair of congenital aortic aneurysm with cleft sternum
Yasutaka Hirata, MD, Marc S. Arkovitz, MD, Charles C. Marboe, MD, and Ralph S. Mosca, MD,
New York, NY
771 Successful bilateral lung transplant from a donor with a tracheal right upper
lobe bronchus
Jeroen M. H. Hendriks, PhD, Ivo Deblier, MD, Bjorn Dieriks, MD, Annelies Janssens, MD,
Willy Coosemans, PhD, Pieter ten Broecke, MD, and Paul Van Schil, PhD, Edegem and
Leuven, Belgium
773 Transcatheter aortic valve intervention through the axillary artery for the
treatment of severe aortic stenosis
Anita W. Asgar, MD, Michael J. Mullen, MD, Nicola Delahunty, Simon W. Davies, MD,
Miles Dalby, MD, Mario Petrou, MB, Andrea Kelleher, MB, and Neil Moat, MS, London, UK
775 Palliative bidirectional Glenn anastomosis for unresectable metastasis in the
right ventricle from renal cell carcinoma 16 years after nephrectomy
Naoto Morimoto, MD, Keisuke Morimoto, MD, Yoshihisa Morimoto, MD, Toshihito Sakamoto, MD,
Akiko Tanaka, MD, Masamichi Matsumori, MD, Kenji Okada, MD, and Yutaka Okita, MD,
Kobe, Japan
777 Repair for acute type A aortic dissection with a long elephant trunk technique
Hiroki Hata, MD, PhD, Koichi Toda, MD, PhD, Yasuhiro Shudo, MD, Satoshi Kainuma, MD,
Kiyoshi Yoshida, CE, Keiji Yamamoto, CE, and Kazuhiro Taniguchi, MD, PhD, Sakai, Japan
779 Left atrial hybrid closure of muscular ventricular septal defects with the
Amplatzer device
Christopher W. Baird, MD, Herbert Stern, MD, and Larry Watts, MD, Charlotte, NC
Brief Communications:
Research
781 The particle gel immunoassay as a rapid test to rule out heparin-induced
thrombocytopenia?
Katharina Schallmoser, MD, Camilla Drexler, MD, Eva Rohde, MD, Dirk Strunk, MD,
Andrea Groselj-Strele, MSc, Gerhard Lanzer, MD, Hartmut Kroll, MD, and Simon Panzer, MD,
Graz, Austria; Dessau, Germany; and Vienna, Austria
783 A potential of autologous pericardium for a sustained-release carrier of
vancomycin: A pilot study in vitro
Akira Marui, MD, PhD, Keiichi Hirose, MD, PhD, Hisashi Sakaguchi, MD, Yoshio Arai, MD, PhD,
Kazuhiko Doi, MD, PhD, Masaki Tsukashita, MD, Takeshi Shimamoto, MD, Tadashi Ikeda, MD,
PhD, and Masashi Komeda, MD, PhD, Kyoto, Japan
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Letters to the Editor 785 Preoperative and intraoperative considerations for radial artery anomalies in
coronary artery bypass grafting
Edward W. K. Peng, MRCS, and Pradip K. Sarkar, FRCS, Sheffield, United Kingdom
785 Reply to the Editor
Chee Fui Chong, MD(Lond), FRCSEd(CTh), BSc(Lond), Brunei, Darussalam
786 Inappropriate comparison of survival rates at 30 days in transplanted patients
previously implanted or not with left ventricular assist devices
Andrea Messori, PharmD, and Sabrina Trippoli, PharmD, Firenze, Italy
787 Reply to the Editor
Joseph C. Cleveland, Jr, MD, Denver, CO
787 Nonoperative management of an extensive tracheal injury in an 860-g
preterm neonate
Christopher W. Baird, MD, Larry T. Watts, MD, and Karen J. Lessaris, MD, Charlotte, NC
788 Reply to the Editor
Chadrick E. Denlinger, MD, and Daniel Kreisel, MD, PhD, St Louis, Mo
788 Preoperative coronary study in patients with acute aortic dissection
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